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The aqueous extract of Derris reticulata Craib. (Leguminosae) has been 
shown to exhibit an anti-diabetic activity both in in vitro study and in alloxan-induced 
diabetic rats. It was proposed that the anti-diabetic activity was due to its 
cytoprotective effect; probably by its antioxidant activity. Moreover, the activity of 
extract has been shown to inhibit the enzyme α-glucosidase. However, the aqueous 
extract used in the previous study contained many compounds; it was difficult to 
identify the active ingredients that are responsible for antioxidant and anti-diabetic 
actions. Therefore, the main objective of this study was to compare antioxidant and 
anti-diabetic activities of D. reticulata stem extract obtained by sequential extraction 
method with three different solvents; hexane, chloroform and water. The results from 
TLC showed that the compositions of the hexane extract were similar to those of the 
chloroform extract, but quite different from those of the aqueous extract. 
Phytochemical analysis revealed that all extracts consisted of triterpenoids, tannins 
and polyphenol whereas cardiac glycoside and anthraquinone were absent. Flavonoids  
and alkaloids were detected only in the hexane and chloroform extracts while saponin  
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was present only in the aqueous extract. The antioxidant activities were studied by 
DPPH, ABTS and FRAP methods. It was found that all three extracts of D. reticulata 
had in vitro antioxidant effects with different degrees of potency depending on the 
method used. The result from cytotoxicity demonstrated that the aqueous extract 
produced the least toxic effect to HepG2 cells since the highest dose up to 5,000 µg/ml 
did not cause significant cell damage compared to control. In contrast, at  
concentrations higher than 60 µg/ml, the hexane and chloroform extracts significantly 
reduced cell viability (P<0.05). It was found that only the aqueous extract with high 
doses (500 and 5,000 µg/ml) showed significant cytoprotective effects from 50.00 ± 
3.48% (alloxan-treated group) to 62.41 ± 3.48% and 69.46 ± 3.77%, respectively. For 
the effect on α-glucosidase enzyme, the result showed that the chloroform extract 
produced highest degree of enzyme inhibition followed by the hexane extract. In the 
case of the aqueous extract, the inhibitory activity was 600 times less than the 
chloroform extract. Together with the results from TLC, it was suggested that the 
major constituent detected at the Rf = 0.854 may be responsible for α-glucosidase 
inhibitory activity of the hexane and chloroform extracts. However, further 
experiments, such as the isolation and identification of this compound as well as the 
examination of its antioxidant, α-glucosidase inhibitory and anti-diabetic activities, are 
needed for verification.  
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และคลอโรฟอร์ม   ฤทธ์ิตา้นอนุมูลอิสระของสารสกดัถูกตรวจสอบโดยวิธี ABTS, DPPH และ
FRAP   ผลการทดสอบช้ีวา่ สารสกดัทั้งสามของล าตน้ชะเอมเหนือมีฤทธ์ิตา้นอนุมูลอิสระท่ีแตกต่าง
กนัออกไปข้ึนอยูก่บัวธีิท่ีใชใ้นการทดสอบ ผลจากการทดสอบความเป็นพิษแสดงให้เห็นวา่สารสกดั
ดว้ยน ้ามีความเป็นพิษต่อเซลล์ตบันอ้ยท่ีสุด เน่ืองจากความเขม้ขน้ท่ีสูงถึง 5,000 µg/ml ไม่ท าให้เกิด
ความเสียหายต่อเซลลอ์ยา่งมีนยัส าคญัเม่ือเปรียบเทียบกบักลุ่มควบคุม   ในทางตรงกนัขา้มพบวา่สาร
สกดัเฮกเซนและคลอโรฟอร์มท่ีความเขม้ขน้มากกว่า 60 µg/ml ลดการรอดตายของเซลล์อย่างมี
นยัส าคญั และพบต่อไปอีกว่ามีเพียงสารสกดัดว้ยน ้ าท่ีความเขม้ขน้สูงท่ี 500 และ 5,000 µg/ml 
เท่านั้นท่ีมีฤทธ์ิปกป้องเซลล์ไดอ้ยา่งมีนยัส าคญั   คือเพิ่มการรอดตายของเซลล์จาก 50.00 ± 3.48% 
ไปเป็น 62.41 ± 3.48% และ 69.46 ± 3.77% ตามล าดบั   ส าหรับการศึกษาฤทธ์ิต่อเอนไซมแ์อลฟา-
กลูโคซิเดสพบว่าสารสกัดคลอโรฟอร์มมีฤทธ์ิในการยบัย ั้งเอนไซม์สูงท่ีสุดตามด้วยสารสกัด
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เฮกเซน   ในส่วนของสารสกดัดว้ยน ้าพบวา่มีฤทธ์ิในการยบัย ั้งเอนไซมต์ ่ากวา่สารสกดัคลอโรฟอร์ม
ถึง 600 เท่า   เม่ือน าผลการทดลองจาก TLC มาพิจารณาร่วมกนั   พบวา่เป็นไปไดท่ี้สารประกอบ
หลกัท่ี Rf = 0.854 บนแผน่ TLC อาจจะมีความเก่ียวขอ้งกบัฤทธ์ิยบัย ั้งเอนไซมก์ลูโคซิเดสของสาร
สกดัเฮกเซนและคลอโรฟอร์ม   อย่างไรก็ตามส าหรับขอ้เสนอแนะน้ียงัตอ้งมีการทดลองเพิ่มเติม 
เช่น การแยกสารสกดัให้บริสุทธ์ิและระบุชนิดของสารน้ี   รวมไปถึงการทดสอบฤทธ์ิตา้นอนุมูล
อิสระ ฤทธ์ิยบัย ั้งเอนไซมก์ลูโคซิเดสและฤทธ์ิตา้นเบาหวาน เพื่อยนืยนัความถูกตอ้งต่อไป 
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CHAPTER I 
INTRODUCTION 
 
1. Rationale 
 Nowadays, advanced technology brings about the knowledge and 
understanding in human diseases, especially diabetes mellitus. Diabetes mellitus is not 
only a major public health problem worldwide but also causes 5% of all deaths 
globally each year (Joshi and Shrestha, 2010). Moreover, the prevalence of this 
disease for all age groups has been predicted to be double in 2020 (Shaw, Sicree, and 
Zimmet, 2010). Diabetes mellitus is a chronic metabolic disorder characterized by 
hyperglycemia resulting from reduction of insulin secretion and/or insulin resistance. 
Eventually, the main cause of death for diabetic patients does not come from the 
disease itself. The patients with diabetes mostly die from various complications for 
example cardiovascular diseases, hypertension and nephropathy (American Diabetes 
Association, 2012). It has been suggested that oxidative stress is partly involved in 
these complications (Dominique, 2002; Mshelia, 2004).    
 Oxidative stress is the condition that the body has less amount of antioxidant 
compared to the amount of free radicals. Free radicals are unstable molecules with 
unpaired electrons in their outer orbits. They are reactive molecules generated by 
cellular processes and environmental stress such as immune system, electron transfer, 
cellular respiration, chemical substances and UV radiation. The excess of free radicals 
damages DNAs, proteins and lipids leading to cellular dysfunction, cellular injury
 
 
 
 
 
 
 
 
2 
 
and  cell death (Kannan and Jain, 2000). Normally, the free radicals mentioned above 
can be removed from the body by antioxidant pathways, either enzymatic or non-
enzymatic systems, such as superoxide dismutase, catalase, glutathione peroxidase, 
and thiol antioxidant. Moreover, the excess free radicals can also be destroyed by 
external antioxidants such as supplements containing vitamin C, flavonoids and 
carotenoids, which can be found in plants, vegetables and fruits (Valko et al., 2007). 
Therefore, natural products from plants have been used as alternative medicines for 
the treatment of many diseases. Moreover, it has been accepted that they usually cause 
fewer side effects than synthetic chemicals (Blasa, Gennari, Angelino, and Ninfali, 
2010). 
Derris reticulata Craib. is a medicinal plant in the Leguminosae family. This 
climbing plant is known in Thai as Cha-em-nuea. It has long been traditionally used as 
expectorant to relieve cough.  Moreover, anti-inflammatory activity in arthritis and 
anti-herpes simplex virus type I (Laupattarakasem, Houghton, Hoult, and Itharat, 
2003; Wisetsutthichai, Techamahamaneerat, Junyaprasert, and Soonthornchareonnon, 
2005) have been reported. Recently, the aqueous extract of D. reticulata has been 
shown to exhibit an anti-diabetic activity by both in vitro and in vivo studies 
(Kumkrai, Kamonwannasit, and Chudapongse, 2014).  It was proposed that the anti-
diabetic activity of D. reticulata was partly due to its cytoprotective effect, probably 
by an antioxidant activity (Kumkrai, Weeranantanapan, and Chudapongse, 2015). 
However, the aqueous extract used in the previous study contained many compounds; 
it was difficult to identify the active ingredients that are responsible for antioxidant 
and anti-diabetic activities. Therefore, in the present study D. reticulata stem was 
successively extracted with different solvents in the increasing polarity order (hexane, 
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chloroform and water). Phytochemical screening test and the examination of their 
compositions and antioxidant activities were performed. Moreover, the cytoprotective 
effects of the extracts on human hepatoma HepG2 cells were evaluated.  Finally, the 
inhibitory activities against α-glucosidase enzyme, which is one of the known target 
molecules of anti-diabetic agents, were conducted and compared. The results from this 
study will provide useful information for the future investigation to identify active 
ingredients that are responsible for anti-diabetic activity of D. reticulata. 
 
2. Research objectives 
2.1 To compare the phytochemical compositions and phenolic contents 
among hexane, chloroform and aqueous extracts of D. reticulata stem. 
2.2 To compare antioxidant activities and cytoprotective effects of the 
extracts. 
2.3 To compare α-glucosidase inhibitory activities of the extracts. 
 
3. Research hypothesis 
The three extracts possess different degrees of antioxidant activity, 
cytoprotective potential and α-glucosidase inhibitory effect. The hexane extract shows 
the highest degree of all activities. 
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4. Scope and limitation of study 
All of the pharmacological activities in the present study were evaluated only 
by in vitro experiments.   
 
 
 
 
 
 
 
 
 
 
CHAPTER II 
LITERATURE REVIEW 
 
2.1 Derris reticulata Craib. 
Several plants in Derris genus, which belong to the Leguminosae family and 
are distributed in the tropical regions of Asia and East Africa, are known to be used as 
traditional medicines (Tewtrakul, Cheenpracha, and Karalai, 2009). Some of Derris 
plants have been used as fish poison and insecticide (Luitgards-Moura, Castellón 
Bermudez, Rocha, Tsouris, and Rosa-Freitas, 2002; Hu et al., 2005; Kongjinda, 2004). 
However, many pharmacological activities of the plants in Derris genus have also 
been documented.  For example, they have been used for the treatment of rheumatism 
and nociceptive (Laupattarakasem et al., 2003; Srimongkol et al., 2007). Some species 
in this genus plants show expectorant activity, therefore they are used to relieve cough 
(Siri Ruckhachati Nature Park, 2010). Moreover, antimicrobial activities of Derris 
plants have been cumulatively reported as well. Microbes in 25 species have been 
reported to susceptible to the extracts from D. elliptica, D. indica  and D. trifoliate 
(Khan, Omoloso, and Barewai, 2006). The ethyl acetate extract of D. indica shows an 
inhibitory effect on growth of Staphylococcus aureus, S. epidermidis and Escherichia 
coli (Sittiwet and Puangpronpitag, 2009). In addition, anti-inflammatory activity of D. 
scanaens (Laupattarakasem et al., 2003), and intestinal α-glycosidase inhibitory 
activity of D. indica (Rao et al., 2009) have been established. Not long ago, the 
antidiarrheal activity of D. trifoliate Lour has been shown and its active ingredients 
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have been identified (Mamoon and Azam, 2012). The biological actions of Derris 
plants are listed in Table 2.1.   
 
Table 2.1 Biological activities of Derris plants. 
Sources Part of use Ethnomedical 
activity 
References 
D. amazonica Root Fish poison 
Insecticide 
Luitgards-Moura et al.,  
2002 
D. elliptica Root Insecticide 
Antimicrobial 
Hu et al., 2005 
Khan et al., 2006 
D. scandens Stem 
Root 
Rheumatism  
Anti-inflammatory 
activity 
Analgesic 
Laupattarakasem et al.,  
2003  
Srimongkol et al., 2007 
D. spruceana Leaf Fish poison Kongjinda, 2004 
D. reticulata 
 
Stem bark 
Stem 
Leaf 
Anti-coughing 
Expectorant 
Anti-diabetic  
Intestinal                 
α-glucosidase 
inhibition 
Antioxidant 
Cytotoxicity 
Anti-inflammation 
Anti-herpes simplex 
virus type 1 
Siri Ruckhachati    
Nature Park, 2010 
Laupattarakasem et al.,  
2003 
Wisetsutthichai et al., 
2005 
Kumkrai et al., 2014 
D. indica Stem 
Root 
Leaf 
Antimicrobial 
Intestinal  
α-glucosidase 
inhibitory 
Khan et al., 2006 
D. trifoliate Stem 
Root 
Leaf 
Antimicrobial  
Antidiarrheal 
 
Khan et al., 2006 
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D. reticulata (Figure 2.1), which is known in Thai as Cha-aim-nuea or Oi-
sam-suan, has been traditionally used as an anti-coughing and anti-inflammatory 
agents (Siri Ruckhachati Nature Park, 2010; Laupattarakasem et al., 2003).  It has also 
been demonstrated that the extract from D. reticulata possesses an antiviral against 
herpes simplex virus type 1 (Laupattarakasem et al., 2003; Wisetsutthichai  et al., 
2005).  
 
                  
Figure 2.1 Flowers (a) and seed pods (b) of Derris reticulata Craib. (Siri   
Ruckhachati   Nature   Park, 2010). 
 
Medicinal plants contain some organic compounds which provide definite 
physiological or pharmacological actions on the human body such as antioxidant 
activity, antimicrobial effect, stimulation of the immune system and anticancer 
property (Saxena, Saxena, Nema, Singh, and Gupta, 2013) as listed in Table 2.2. 
These bioactive substances include alkaloids, flavonoids, saponins, tannins, 
triterpenoids, cardiac glycosides, anthraquinones, and polyphenols (Dillard and 
(a) (b) 
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German, 2000). From phytochemical screening study, the stem of D. reticulata 
consists of terpenoids, flavonoids, saponin and tannins (Kumkrai et al., 2014).  
 
Table 2.2 Examples of the bioactive phytochemicals in plants (Saxena et al., 2013). 
Classification Main groups of compounds Biological functions 
NSA 
(non-starchpoly 
saccharides) 
Cellulose  
Hemicellulose  
Gums 
Mucilages  
Pectins 
Lignins 
Water holding capacity 
Delay in nutrient absorption 
Binding toxins and bile acids 
Antibacterial and 
antifungal 
 
Terpenoids  
Alkaloids 
Phenolics 
Inhibotors of micro-  
oraganisms 
Reduced the risk of fungal 
Infection 
Antioxidants  Polyphenolic compounds 
Flavonoids 
Carotenoids 
Tocopherols  
Ascorbic acid  
Polyphenol 
Oxygen free radical 
quenching 
Inhibition of lipid 
peroxidation 
 
Anticancer  Carotenoids 
Polyphenols 
Flavonoids 
Inhibitors of tumor 
Inhibited development of 
lung cancer 
Anti-metastatic activity 
Detoxifying agents Reductive acids 
Tocopherols  
Phenols  
Indoles  
Aromatic isothiocyanates 
Coumsrins  
Flavones  
Carotenoids 
Retinoids 
Inhibitors of procarcinogen 
activation 
Inducers of drug binging of 
carcinogens 
Inhibitors of tumourogenesis 
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Flavonoids have been demonstrated to possess a variety of biological activities 
including antibacterial, antiviral, antioxidant, antiulcerogenic, antineoplastic, 
antihepatotoxic, anti-inflammatory activities and cytotoxicity (Cushnie and Lamb, 
2005; Pengelly, 2004). Lupinifolin is a prenylated flavanone which was found to be a 
major compound in stem and stem bark of D. reticulata Benth (Mahidol et al., 1997). 
However, it can be isolated  from  other medicinal plants,  such as Myriopteron 
extensum (Soonthornchareonnon, Ubonopas, Kaewsuwan, and Wuttiudomlert, 2004),  
Eriosema chinense (Prasad et al., 2013) and Albizia myriophylla (Joycharat et al., 
2013). Lupinifolin is a compound of whose characteristics is less soluble in water, but 
easily soluble in methanol, ethanol, trichoromethane, and other organic solvents. It has 
been shown to exhibit antimicrobial activities against several pathogens such as herpes 
simplex virus type 1 (Soonthornchareonnon et al., 2004), Mycobacterium  tuberculosis 
(Sutthivaiyakit et al., 2009), Bacillus cereus, Corynebacterium diphtheria and S. 
epidermidis (Soonthornchareonnon et al., 2004; Sutthivaiyakit et al., 2009).  
Recently, the aqueous extract of D. reticulata has been reported to possess 
anti-diabetic activity. This therapeutic potential has been studied both in vitro and in 
vivo (Kumkrai et al., 2014). Moreover, Kumkrai and co-workers have demonstrated 
that the mechanisms underlying the anti-diabetic activity of D. reticulata aqueous 
extract are the combination of cytoprotective effect, suppression of intestinal glucose 
absorption and inhibition of α-glucosidase activity. However, the active ingredients 
have not yet been identified. Further studies should include the isolation and 
identification of the active chemical(s) responsible for the protective effect and α-
glucosidase activity of D. reticulata extract. 
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2.2 Free radicals and antioxidant  
Free radicals are unstable molecules with unpaired electrons in their outer 
orbits. These free radicals can withdraw electron from other molecules. They are 
reactive molecules generated by cell processes and environmental stress such as 
immune system, electron transfer, cellular respiration, chemical substances and UV 
radiation. The free radicals can damage DNAs, proteins and lipids leading to cellular 
dysfunction, cell injury and cell death. Excessive free radicals cause inflammation, 
cancer, premature aging disorder, atherosclerosis and diabetes (Kannan and Jain, 
2000). 
Among various free radicals, reactive oxygen species (ROS) is the most 
important class generated in living systems. ROS can be classified into two categories 
as follows: free oxygen radicals and non-radical ROS for example hydrogen peroxide 
(H2O2), superoxide radical (O2
-
) and hydroxyl radical (OH
.
).  
 Superoxide (O2
-
) is the primary ROS occurred from electron transport chain 
in mitochondria of the cell. Moreover, O2
- 
can further interact with other molecules to 
generate secondary ROS. For example, the O2
-
 is formed by the process of reduction 
of molecular oxygen mediated by NAD(P)H oxidase and xanthine oxidase. Then, the 
O2
-
 is dismutated by superoxide dismutase to H2O2. Finally, the H2O2 can split to OH
.
 
by Fenton reaction (Figure 2.2). 
 
 
Figure 2.2 The pathways of ROS formation. 
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The free radicals mentioned above can be removed from the body by 
antioxidant pathways including superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) as shown in Figure 2.3. In addition, the excess free 
radicals can be destroyed by external antioxidants such as supplements containing 
vitamin C, flavonoids and carotenoids, which can be found in plants, vegetables and 
fruits (Valko et al., 2007). 
 
 
Figure 2.3 The pathways of antioxidant in scavenging free radicals. 
 
2.3 Diabetes mellitus  
  Diabetes mellitus is a chronic metabolic disorder characterized by 
hyperglycemia resulting from reduction of insulin secretion and/or insulin resistance.  
Insulin is an important hormone involved in the regulation of the blood glucose level 
by stimulating removal of glucose from the blood as shown in Figure 2.4 (Yeo and 
Sawdon, 2013). If the insulin cannot function efficiently, the glucose cannot be used as 
a primary source of energy. Therefore, the body shifts to use fat and protein as an 
energy source (American Diabetes Association, 2012).  
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Figure 2.4 The role of insulin in control of blood glucose (Martini, Ober, Garrison, 
Welch, and Hutchings, 2006). 
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2.3.1 Symptoms of diabetes mellitus 
Diabetes results in metabolic imbalance of carbohydrate, lipid and protein. 
The fasting plasma sugar more than 126 mg/dL or more than 200 mg/dL for glucose 
tolerance test are considered as diabetes (Olokoba, Obateru, and Olokoba, 2012). 
Moreover, most of diabetes symptoms of patient are polyuria, polydipsia and 
polyphagia including glucosuria (American Diabetes Association, 2012). The 
symptoms of diabetes can be explained as follows: 
1)  Due to the level of blood sugar being higher than the capability of the 
kidneys to reabsorb; therefore the excess blood sugar is excreted to the urine. The 
presence of blood sugar in urine increases the urine quantity because of the ability of 
glucose molecules to absorb the water. This condition is called glucosuria. 
2)  Polyuria or increased urination frequently in a diabetic patient leads to body 
dehydration and eventually to polydipsia or increased thirst. 
3)  The polyphagia or excessive appetite of the diabetes patient results from the 
failure of glucose utilization, leading to more consumption in order to take more 
energy from the other sources. 
2.3.2 Types of diabetes mellitus 
 Diabetes mellitus can be classified into 2 types (Table 2.3) as follows: type 1 
diabetes (insulin dependent diabetes mellitus) and type 2 diabetes (non-insulin 
dependent diabetes mellitus). Diabetes type 1 is caused from beta-cell damage. The 
damage of beta cells makes insulin production decrease. Therefore, the diabetes 
patients need insulin injections to acquire the normal blood sugar level. Diabetes type 
2 is caused from insulin resistance, which occurs when cells fail to respond to the 
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normal actions of the hormone insulin. This may be caused by genetics, aging or 
obesity.  
 
Table 2.3 The two major types of diabetes mellitus. 
 Type 1 diabetes 
(insulin dependent  
diabetes mellitus) 
Type 2 diabetes 
(non-insulin dependent 
 diabetes mellitus) 
Cause of disease Destruction of β-cells Reduction of insulin secretion 
and/or insulin resistance 
Prevalence of disease  About 5-10% About 90-95% 
Age < 20 year old >20 year old 
Symptom Hyperglycemia Hyperglycemia 
Treatment Insulin Insulin secretagogues 
Metformin 
α-Glucosidase inhibitors, etc. 
 
2.3.3 Diabetic complications 
  An abnormality of blood glucose concentration can lead to many health 
problems and subsequently to death (Yeo and Sawdon, 2013). The main cause of 
death for diabetes patients does not come from the disease itself. Patients with diabetes 
mostly die from various complications for example cardiovascular diseases, 
hypertension and nephropathy (American Diabetes Association, 2012). However, 
oxidative stress is partly involved in these complications as shown in Figure 2.5 
(Dominique, 2002; Mshelia, 2004).  
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Figure 2.5 The relationship of free radicals and diabetic complications. 
 
2.3.4 Glucose and formation of free radical  
Previous studies showed the relationship between the development of 
diabetes and the level of oxidative stress in diabetic patients (Mshelia, 2004). The 
increasing sugar level causes an elevation of oxidant level and/or decreases the 
function of antioxidants (Dominique, 2002), resulting in an oxidative stress. The 
formation of free radicals in the body has also been found in different mechanisms, 
such as glucose oxidation, non-enzymatic glycation of proteins, polyol pathway, 
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hexosamine pathway and electron transport chain (Bierhaus, Hofmann, Ziegler, and 
Nawroth, 1998; Dominique, 2002), as shown in Figure 2.6-2.8. 
 
 
Figure 2.6 The formation of ROS under metal catalyzed autoxidation of glucose 
(Bierhaus et al., 1998). 
 
 
Figure 2.7 Sources of ROS under the influence of hyperglycemia (Radoi, Lixandru, 
Mohora, and Virgolici, 2012). 
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Figure 2.8 Polyol pathway-induced oxidative stress. The polyol pathway decreases 
function of antioxidant via NADPH and produces free radical (Chung, Ho, Lam, and 
Chung, 2003). 
 
2.4 Free radical on nephropathy 
Diabetic nephropathy is one of the complications which are causes of death 
for diabetic patients. The pathophysiology of diabetic nephropathy starts with the 
endothelial cell dysfunction (ECD) and ends with renal failure (Mshelia, 2004). High 
glucose can directly cause ECD or indirectly increase oxidative stress in glomerular 
mesangial cells which is a target cell in diabetic nephropathy (Figure 2.9). As shown 
in Figure 2.10, oxidative stress induces mRNA expression of NFkB gene which in turn 
promotes production of proinflammatory such as TGF, IL-6 and PDGF. These 
cytokine are part of the abnormal blood pressure deregulation and renal fibrosis. 
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Figure 2.9 The sequence of events in the pathogenesis of diabetic nephropathy 
(Mshelia, 2004). 
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Figure 2.10 The cytokines in the pathogenesis of diabetic nephropathy (Mshelia, 
2004). 
 
2.5 Thin layer chromatography 
Thin layer chromatography (TLC) is a method for analyzing the number of 
components in a mixture by separating the compounds in the mixture. Moreover, TLC 
can used for identification and purification of a compound (Bele and Khale, 2011; 
Sherma and Fried, 2003). TLC is generally regarded as a simple, rapid, and 
inexpensive method for the separation, tentative identification, and visual 
semiquantitative assessment of a wide variety of substances (Harborne, 1998; Wagner 
and Bladt, 1996). The steps of TLC are shown in Figure 2.11. If components of the 
reaction are colored, no visualization method is required because spots can be seen 
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directly on the silica layer. However, many substances cannot be seen easily, therefore 
one of the non-destructive methods such as viewing ultraviolet-active compounds 
under an ultraviolet lamp or one of destructive methods such as staining with some 
reagents should be used to reveal the spots. Moreover, there are many available TLC 
visualization reagents, for example aluminium chloride for detection flavonoids, 
formaldehyde/sulfuric acid for detection of alkaloids, and formaldehyde/phosphoric 
acid for detection of steroid alkaloids, steroid sapogenins and phenothiazine 
derivative. 
 
 
Figure 2.11 The three steps of TLC (Bele and Khale, 2011). 
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2.6 Methods for antioxidant measurement 
The methods for antioxidant measurement can be classified into two types 
based on the reaction involved, including hydrogen atom transfer (HAT) and electron 
transfer (ET) reactions (Prior, Wu, and Schaich, 2005; Karadag, Ozcelik, and Saner, 
2009). The ET-based assays measure the capacity of an antioxidant in the reduction of 
an oxidant, which changes color when reduced. The degree of color change correlates 
with the antioxidant activity while HAT-based assays apply a competitive reaction. 
Oxygen radical absorbance capacity (ORAC) is a sample of HAT reaction. The ORAC 
assay is considered to be more relevant because it utilizes a biologically relevant 
radical source (Cao, Alessio, and Cutler, 1993). Although ORAC assay is sensitive, 
this assay requires detection by fluorometer, which may not be routinely available in 
analytical laboratories. Conversely, ABTS, DPPH and FRAP assays are examples of 
ET reaction. These assays are routinely available in laboratories and usually used for 
initial screening for antioxidative compounds because they are simple, inexpensive, 
and rapid (Antolovich, Prenzler, Patsalides,  Mcdonald, and Robards, 2002; Prior et 
al., 2005). 
2.6.1 ABTS radical scavenging activity assay 
 ABTS radical scavenging activity assay is a method for determination of 
antioxidant activity by using 2,2’-azino-bis(3-ethylbenzoline-6-sulfonic acid) 
diammonium salt (ABTS) as stable radical  (Miller, Rice-Evans, Davies, Gopinathan, 
and Milner, 1993). The ABTS changes to ABTS
.+
 radical cation by potassium 
permanganate or potassium persulfate; this solution shows green color. The ability in 
scavenging free radicals of ABTS assay will be detected by spectrometer at 734 nm 
for measuring the reduction in color. The color of ABTS
.+
 radical cation decreases 
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when reacting with an antioxidant compound (Figure 2.12). The degree of color 
change correlates with the antioxidant activity (Antolovich et al., 2002). ABTS
.+
 can 
be solubilized in both aqueous and organic media. Thus, this method can determine 
both the hydrophilic and lipophilic nature of the compounds (Karadag et al., 2009). 
 
 
Figure 2.12 The reaction of ABTS assay. 
 
2.6.2 DPPH radical scavenging activity assay 
 DPPH radical scavenging activity assay is a method to determine antioxidant 
capacity (Blois, 1958). This method uses DPPH reagent as stable radical. The DPPH 
reagent shows purple color in methanol solution. The ability in scavenging free 
radicals in DPPH assay is detected by spectrometer at 517 nm. The purple color of the 
DPPH radical will change to yellow color when the DPPH reacts with the antioxidant 
compound (Figure 2.13). Yellow color which occurs after reaction correlates with the 
antioxidant activity. However, the DPPH method limits is of limited use with 
hydrophilic oxidants because the DPPH can only be dissolved in alcoholic media 
(Karadag et al., 2009). 
 
 
Figure 2.13 The reaction of DPPH assay. 
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2.6.3 Ferric reducing antioxidant power (FRAP) assay 
FRAP assay is a method for determination of antioxidant capacity (Benzie 
and Strain, 1996). This method is based on the reduction of the Fe
3+
 complex (Fe 
(TPTZ)
 3+
) to Fe
2+
 complex (Fe (TPTZ)
 2+
) by antioxidants (Figure 2.14). The Fe 
(TPTZ)
 2+
 complex shows blue color which is correlated with the reducing power. The 
blue color occurring after the reaction can be measured by spectrometer at 593 nm. 
The reduction of (Fe (TPTZ)
 3+
) to (Fe (TPTZ)
 2+
) is defined as antioxidant power, 
reflecting to its action of reducing reactive species (Karadag et al., 2009). 
 
 
Figure 2.14 The reaction of FRAP assay. 
 
2.7 Alloxan 
Alloxan is the most prominent chemical compound used to induce diabetes in 
animals such as rabbits (Alam, Khan, Sirhindi, and Khan, 2005), mice (Heikkila, 
1977), and rats (Raut and Gaikwad, 2006). The structure of alloxan resembles that of 
glucose (Figure 2.15). Its molecule is hydrophilic and does not penetrate the lipid 
bilayer of the plasma membrane. Thus, its process to penetrate to the cell depends on 
the GLUT2 glucose transporter (Elsner, Tiedge, Guldbakke, Munday, and Lenzen, 
2002). Alloxan induces diabetes by generating reactive oxygen species such as 
superoxide, hydrogen peroxide and hydroxyl radicals. These radicals are ultimately 
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responsible for the death of the beta cells (Lenzen, 2008). Moreover, GLUT2 glucose 
transporter can be found in liver and kidney cells. In this study, alloxan was used as 
oxidative stress agent for studying the protective effects of the extracts of D. 
reticulata. 
 
 
Figure 2.15 Chemical structure of alloxan (Lenzen, 2008). 
 
2.8 HepG2 cell  
HepG2 cell or hepatocellular carcinoma is a perpetual cell line which was 
derived from the liver tissue of a 15-year old Caucasian American male. The 
morphological features of HepG2 cells are illustrated in Figure 2.16. HepG2 cells are 
suitable for in vitro model system for the study of polarized human hepatocytes, for 
example liver metabolism (Hirayama et al., 1993), cytoprotective effect (Thabrew, 
Hughes, and Mcfarlane, 1997), and hepatotoxicity study (Neuman, Koren, and 
Tiribelli, 1993). The liver plays many essential roles in maintaining normal 
physiology. It is also a vulnerable target of many drugs or other chemicals because the 
liver is involved in complex metabolism. Therefore, the liver is one of the primary 
organ tested in drug and chemical safety evaluations. In this study, HepG2 cell was 
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used as a representative cell type to study the protective effects of D. reticulata 
extracts. 
 
Figure 2.16 Photographs of HepG2 cells (American Type Culture Collection, 2014). 
 
2.9 Methods for cell viability measurement 
Quantification of cell viability is an indispensable tool for various biological 
studies, including cancer biology, microbiological resistance, and compound toxicity 
(Marks, Belov, Davey, Davey, and Kidman, 1992; Montoro et al., 2005; Wu, Liao, and 
Chang, 1993). 
2.9.1 Trypan blue exclusion method 
The trypan blue exclusion method is the stain most commonly used to 
distinguish viable from nonviable cells. The principle of this method is based on cell 
membrane integrity (Strober, 2001). Dead cells absorb TB into the cytoplasm and stain 
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intracellular components making dead cells stained blue because of loss of membrane 
selectivity, whereas live cells remain unstained (Figure 2.17). Thus, the relative 
number of dead and live cells is obtained by optical microscopy by counting the 
number of stained (dead) and unstained (live) cells by using haemocytometer 
(counting chamber, Figure 2.18). In this study, the trypan blue exclusion method was 
used for counting cells in cell preparation. 
 
 
Figure 2.17 Dead and live cells on trypan blue exclusion method. 
 
  
Figure 2.18 Haemocytometer. 
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2.9.2 MTT method 
The MTT method is a quantitative colorimetric method to determine cell 
proliferation and cell viability. The assay is based on the cleavage of the yellow 
tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide] to 
formazan by cellular mitochondrial dehydrogenases (Van Meerloo, Kaspers,and 
Cloos, 2011), which has a purple color (Figure 2.19). The mitochondrial enzyme is 
only active in viable cells. The more viable cells are present, the more formazan purple 
product is produced. The formazan can be measured by spectrophotometer at 570 nm. 
 
 
Figure 2.19 The formazan purple product of tetrazolium salt of MTT assay. 
 
2.10 α-Glucosidase 
The α-glucosidase enzyme, known by other names such as maltase, and 
glucosidosucrase, is one of several enzymes that help digest carbohydrates 
(International Union of Biochemistry and Molecular Biology, 2010). It is located in 
the brush border of the small intestine and takes part in the breakdown of 
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carbohydrates into monosaccharide before absorption. The enzymes responsible for 
carbohydrate digestion in the gastrointestinal system are summarized in Table 2.4. The 
inhibition on intestinal α-glucosidase is one of the therapeutic approaches to decrease 
blood glucose level in the treatment of diabetics patients (Burkhard  and Christine, 
1998), because the inhibition on intestinal α-glucosidase would delay the digestion of 
carbohydrates and reduce the rate of glucose absorption. α-Glucosidase inhibitors, 
such as acarbose, delay carbohydrate digestion by competitively inhibiting α-
glucosidase in the small intestine (Clissold and Edwards, 1988). They are clinically 
useful for the control of postprandial hyperglycemia.  
 
Table 2.4 Summary of carbohydrate digestion. 
Site of 
synthesis 
Site of action Enzyme 
 
Substrate 
 
Product 
 
Salivary gland Mouth α-amylase Starches Polysaccharide, 
Disaccharides 
 Stomach No digestion of carbohydrate 
Pancreas Small 
intestine 
β-amylase Starches Maltose 
Small 
intestine 
Small 
intestine 
Sucrose Sucrose Glucose 
Fructose 
  Maltase 
(α-glucosidase) 
Maltose 2 glucoses 
  Lactase Lactose Glucose 
Galactose 
 
 
 
 
 
 
 
 
 
  
 
 
CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Plant materials 
3.1.1 Collection of plants 
 D. reticulata was collected from Prachinburi province, Thailand by a former 
Ph. D. student (Dr. Pakarang Kumkrai). Its authenticity was identified and confirmed 
using taxonomy based on the definition previously described (Bangkok Herbarium, 
2009; Siri Ruckhachati Nature Park, 2010; Songsak, 1995). The voucher specimen 
(Pharm-Chu-006) was kept at School of Pharmacology, Suranaree University of 
Technology. The collected stems were cut into small pieces and dried at 50ºC in a hot 
air oven, then kept at -20ºC until used.  
3.1.2 Preparation of the extract 
The extracts were obtained by sequential extraction method. First, 60 g of 
dried plants extract with 400 ml of hexane, and then with the same amount of 
chloroform, at 80ºC for 8 h for each solvents by using Soxhlet extractor. After 
extraction with hexane and chloroform the residues were subjected to water decoction 
at 100ºC for 10 min. This process was repeated twice. After that the aqueous extract 
was filtered and centrifuged at 2500 × g for 10 min. All of extracts were collected and 
concentrated by using a rotary evaporator. After that, the concentration was 
lyophilized into powder by a lyophilizer at -40ºC for four days. Finally, the dried 
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extract was stored at -20ºC until used. The percent yield of extract was calculated as:         
         
       
       
     
  where  WF is the weight of extract powder at terminal of extraction 
   WI is the weight of dried plant at initial of extraction 
 
3.2 Thin layer chromatography (TLC)  
TLC was carried out for screening the number of components in the extracts as 
follows. The aqueous extract was dissolved in distilled water whereas the hexane and 
chloroform extracts were dissolved in ethanol. Then, 10 µl (5 µg) of the extracts 
solution were applied on 4×8 cm of TLC plates. After drying, TLC plates were 
transferred to TLC developing tank containing mobile phase [Dichloromethane: 
Methanol (95:5) and Chloroform: Methanol: Water (10:30:1)]. Compositions of each 
extract were first observed under UV lamp. After that, TLC plates were stained with 
10% sulfuric acid for image analysis and Rf value was calculated for the main 
component of the extract. 
          
 
 
 
 where  Y is the distance in movement of component 
   X is the distance in movement of mobile phase 
 
3.3 Phytochemical screening test 
 The phytochemical screening test was conducted for identification of 
components of the extracts. The test involved screening for alkaloids, flavonoids, 
(2) 
(1) 
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saponins, tannins, triterpenoids, cardiac glycosides, anthraquinones, and polyphenol 
by using standard procedures (Harborne, 1998; Saxena and Saxena, 2012). 
3.3.1 Test for alkaloids  
     Mayer’s test 
  Mayer’s reagent was prepared by dissolving 1.358 g of mercuric chloride 
(HgCl2) in 60 ml distilled water, and 5 g of potassium iodide (KI) in 10 ml distilled 
water; then mixed together. Distilled water was added to the mixture to bring the 
volume to 100 ml. Mayer’s reagent (2-3 drops) was added to 1 ml of test sample (0.2 
g/ml) and shaken. The appearance of cream or pale-yellow precipitate indicates the 
presence of alkaloids. 
    Wagner’s test 
  Wagner’s reagent was prepared by dissolving 2 g of iodine and 6 g of KI in 
100 ml of distilled water. 2-3 drops of Wagner’s reagent were added to 1 ml of the 
sample solution (0.2 g/ml) and shaken. The appearance of brown or reddish brown 
precipitate indicates the presence of alkaloids. 
3.3.2  Test for flavonoids 
   Shinoda test 
  A few fragments of magnesium ribbon were added to 1 ml of the extract 
solution (0.2 g/ml) followed by 2-3 drops of concentrated HCl. The appearance of 
pink, crimson red, or green to blue color indicates the presence of flavonoids. 
   Ferric chloride test 
  A few drops of 1% ferric chloride (FeCl3) were added to 1 ml of the extract 
solution (0.2 g/ml) and shaken. The appearance of intense green color indicates the 
presence of flavonoids. 
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3.3.3 Test for saponins 
   Froth test 
  Distilled water (2-3 ml) was added to 0.2 g of the dried powdered extract and 
then, boiled for 10 min. The extract solution was shaken. The appearance of honey 
comb froth that is stable for 15-30 min indicates the presence of saponins. 
3.3.4 Test for tannins  
   Ferric chloride test 
  A few drops of 1% ferric chloride (FeCl3) were added to 1 ml of the extract 
solution (0.2 g/ml) and shaken. The appearance of intense green, purple, blue or black 
color indicates the presence of tannins. 
   Lead acetate test 
  A few drops of 10% lead acetate solution were added to 1 ml of the extract 
solution (0.2 g/ml) and shaken. The appearance of precipitate indicates the presence of 
tannins. 
3.3.5 Test for triterpenoids 
   Salkowski’s test 
  Chloroform was added to 1 ml of the extract solution (0.2 g/ml), followed by 
a few drops of concentrated H2SO4. The sample was shaken and left standing at room 
temperature for 5 min. The appearance of a yellow lower layer indicates the presence 
of triterpenoids. 
3.3.6 Test for cardiac glycosides  
  Keller Killiani test 
  Glacial acetic acid containing 2-3 drops of 2% FeCl3 solution was added to 1 
ml of the extract solution (0.2 g/ml). Then, the mixed solution was transferred to a new 
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tube containing 0.5 ml of concentrated H2SO4. The appearance of blue color in the 
acetic acid layer indicates the presence of cardiac glycosides. 
3.3.7 Test for anthraquinones 
  Borntrager’s  test 
  0.2 g of dried extract was shaken with 1 ml of benzene until the extract 
solution showed organic layer. Then, 1 ml of 10% ammonia solution was added to the 
solution. The appearance of pink, red or violet coloration in the ammonical phase 
indicates the presence of anthraquinones. 
3.3.8 Test for polyphenol 
   Ferric-chloride-ferricyanide test 
  Ferric chloride (1%) and potassium ferricyanide (1%) solutions were added to 
1 ml of the extract solution (0.2 g/ml). The appearance of radish blue color indicates 
the presence of polyphenol. 
 
3.4 Determination of total phenolic content                                                   
   The total phenolic content was determined by the Folin-Ciocalteu method and 
performed according to the previous report (Prior, Wu, and Schaich, 2005) with some 
modifications. In brief, 100 µl of 2.5 mg/ml extract was mixed with 2 ml of 2% 
Na2CO3 and incubated for 2 min at room temperature. After incubation, 100 µl of 
Folin-Ciocalteu reagent (diluted in methanol 1:1 v/v) was added to the reaction 
mixture and incubated in the dark at room temperature for 30 min. After incubation, 
the absorbance was measured at 750 nm by using spectrophotometer. The total 
phenolic content of extract was determined from a standard curve of Gallic acid and 
results were expressed as mg gallic acid equivalents (GAE) per gram extract. 
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3.5 Antioxidant activity determination 
3.5.1  ABTS radical scavenging activity assay 
  ABTS radical scavenging activity assay was performed according to the 
method previously described (Re et al., 1999) with some modifications. The ABTS
.+
 
radical cation stock solution was prepared by mixing 5 ml of 14 mM ABTS with 5 ml 
of 4.9 mM potassium persulphate (K2S2O8) and incubated in the dark at room 
temperature for 16 h. Before use, the ABTS
.+ 
radical cation stock solution was diluted 
with ethanol to attain absorbance of 0.7 ± 0.02 at 734 nm. After that, 50 µl of various 
concentrations of the extract (0-6,000 µg/ml) was mixed with 1.5 ml of diluted 
ABTS
.+
 stock solution. Then, the mixture was incubated in the dark at room 
temperature for 6 min. After incubation, the absorbance was measured at 734 nm by 
using spectrophotometer. Butylated hydroxytoluene (BHT) was used as standard. 
Results were expressed as IC50 (the concentration required for 50% scavenge for free 
radical). The control is the reaction without the extract (0 µg/ml).  
                                        
[                  ]
         
                
 where  ODcontrol is the absorbance of the control reaction 
   ODsample is the absorbance of sample reaction 
3.5.2  DPPH radical scavenging activity assay 
  DPPH radical scavenging activity assay was performed according to the 
previous report (Bor, Chen, and Yen, 2006) with some modifications. DPPH stock 
solution was prepared by dissolving 0.2 M DPPH in methanol and then stored at -20ºC 
until needed. 1 ml of various extract concentrations (0-6,000 µg/ml) was added to 4 ml 
of 0.2 M DPPH solution. Then, the reaction mixture was incubated in the dark at room 
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temperature for 30 min and measured the absorbance at 517 nm using 
spectrophotometer. Ascorbic acid (vitamin C) was used as standard. Results were 
expressed as IC50 (the concentration required for 50% scavenge for free radical). The 
control is the reaction without the extract (0 µg/ml). 
                                      
                    
         
     
 where ODcontrol  and ODsample have the same meanings as in the Equation (3). 
3.5.3 Ferric reducing antioxidant power (FRAP) assay  
   FRAP assay was performed according to the method described by (Benzie 
and Strain, 1996) with some modifications. The FRAP reagent was prepared by 
mixing 10 mM TPTZ solution (2,4,6-tripyridyl-s-triazine), 20 mM FeCl3, and 300 mM 
acetate buffer (pH 3.6), in ratio 1:1:10 (v/v/v). Then, FRAP reagent was incubated in 
water bath at 37ºC until used. A 50 µl of 5 mg/ml extract was mixed with 1.5 ml of the 
FRAP reagent. The reaction mixture was incubated at room temperature for 4 min and 
measured the absorbance at 593 nm. The reducing potential of extract was determined 
from a standard curve of FeSO4 and the FRAP value were expressed as µmol Fe
2+
/mg 
dried extract. 
 
3.6 Determination of cytoprotective effect  
3.6.1  Cells and culture conditions 
 HepG2, Homo sapiens (Human) cell line was obtained from the American 
Type Culture Collection (ATCC number: HB-8065). HepG2 cells were cultured in 
DMEM medium supplemented with 10% fetal bovine serum, 1% antibiotic-
antimycotic solution, 1% HEPES, 1% sodium pyruvate and incubated at 37ºC in a 
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humidified atmosphere containing 5% CO2. Cells were grown as adherent cells and 
spread in culture flask. The cells were sub-cultured at 70-90% confluence. The cells 
were trypsinized with 0.25% trypsin-EDTA. 
3.6.2 Determination of alloxan-induced cell death 
 In order to find the suitable concentration of alloxan for induction of 50% cell 
damage, HepG2 cells with density 4.5 × 10
4
 cells per well were seeded in 96 well 
plates and incubated in a humidified incubator containing 5% CO2 at 37ºC for 16-18 h. 
Then, the cells were treated with alloxan at range of concentration 0-15 mM (dissolved 
in 50 mM citrated buffer pH 3.0). After 2 h of incubation, the medium was removed 
and cells were further incubated for 23 h. Then, the cells were centrifuged 2500 rpm at 
4ºC for 5 min and removed medium. 5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was added for determination of cell viability. 
After that, the samples were incubated in the dark at 37ºC for 4 h. After incubation, the 
cells were centrifuged 2500 rpm at 4ºC for 5 min. The culture medium was discarded 
and the purple formazan crystals were dissolved with DMSO (50 µl per well). MTT 
solution was measured at 570 nm using a microplate reader. Results were expressed as 
percentage of cell viability. 
                             
        
         
                                            
 Where ODsample is the absorbance of the sample after test with MTT  
   ODcontrol is the absorbance of control after test with MTT 
 
 
3.6.3 Determination of the effect of the extracts on cell viability 
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 The effects of D. reticulata extracts on the viability of HepG2 cell was first 
tested to find the range of non-toxic concentrations for further experiments. HepG2 
cells were seeded in 96 well plates at the concentration of 4.5 × 10
4
 cells per well and 
incubated in a humidified incubator containing 5% CO2 at 37ºC for 16-18 h. After 
that, cells were treated with various concentrations of D. reticulata extracts at the 
doses of 0-5000 μg/ml for 24 h. After treatment, the cells were centrifuged 2500 rpm 
at 4ºC for 5 min and removed medium. Then, 5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) was added for determination of cell viability. 
After that, the samples were incubated in the dark at 37ºC for 4 h. After incubation, the 
cells were centrifuged 2500 rpm at 4ºC for 5 min. The culture medium was discarded 
and the purple formazan crystals were dissolved with DMSO (50 µl per well). MTT 
solution was measured at 570 nm using a microplate reader. Results were expressed as 
percentage of cell viability. 
                 
        
         
      
 where ODcontrol and ODsample have the same meanings as in the Equation (4). 
3.6.4 Determination of the effect of D. reticulata extracts on alloxan- 
induced HepG2 cell damage 
 HepG2 cells were plated in a 96 well plate (4.5 × 10
4
 cell per well) and 
incubated in a humidified incubator containing 5% CO2 at 37ºC for 16-18 h. Then, the 
cells were treated with 14 mM alloxan (which caused about 50% of cell death) for 2 h. 
After incubation, the medium was removed. The cells were treated with 60 µg/ml of 
hexane and chloroform extracts while aqueous extract the cells were treated with 60, 
500 and 5000 µg/ml (500 and 5000 µg/ml of aqueous extract shown not toxic to cells) 
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for 22 h. After that, the cells were centrifuged 2500 rpm at 4ºC for 5 min and removed 
from the medium. At the end of experiment, the viable of cells were determined by 
MTT method. 
 
3.7  Determination of α-glucosidase inhibitory activity  
  The α-glucosidase inhibitory activity was determined according to the 
previous reports (Choi et al., 2010; Dong, Li, Zhu, Liu, and Huang, 2012) with some 
modifications. The reaction mixture consisted of 10 µl of 0.1 U/ml α-glucosidase 
enzyme, 50 µl of 0.1 M potassium phosphate buffer pH 6.8 and 20 µl of the test 
sample (the extracts or acarbose as a positive control). Then, the reaction mixture was 
mixed and incubated at room temperature for 10 min. After that, 10 µl of 1 mM p-
nitrophenyl-α-D-glucopyranoside (PNP-G) was added into the reaction mixture and 
incubated at room temperature for 30 min. After incubation, the mixture was added 
with 50 µl of 0.1M Na2CO3 to stop the reaction and the absorbance was measured at 
405 nm. Results were expressed as IC50 (the concentration of inhibitors required for 
inhibiting 50% for α-glucosidase activity). The control is 100 percent of enzyme 
activity in the reaction (added enzyme and PNP-G but not added extract or acarbose). 
                                        
                    
         
     
 where ODcontrol and ODsample have the same meanings as in the Equation (3). 
 
3.8 Data analysis 
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 Data are expressed as mean ± SD and the comparisons among different 
groups were performed by analysis of variance (ANOVA) followed by Student-
Newman-Keuls test. P-values less than 0.05 were considered as significant difference. 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV 
RESULTS 
 
4.1  Yield of Derris reticulata extracts 
 The results in Table 4.1 show that the aqueous extract of D. reticulata gave 
the highest yield (10.56%) compared to the chloroform and hexane extracts with 
2.68% and 2.02% yields, respectively.  
 
Table 4.1 Yields of the chloroform, hexane, and aqueous extracts from D. reticulata       
       stem. 
Extract Total dry plant (g) 
(6 times, 60 g each) 
Powder (g) % Yield 
Hexane  360 7.279 2.02 
Chloroform 360 9.65 2.68 
Aqueous  360 38.02 10.56 
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4.2  Compositions of the extracts detected by TLC  
 The TLC finger prints shown in Figure 4.1 revealed that the chloroform and 
hexane extracts contained some similar constituents, and the major compound in both 
extracts was the compound with Rf = 0.854. In addition, more compounds were 
observed in the chloroform extract than in the hexane extract. In the case of aqueous 
extract, the compounds were not separated well in both types of mobile phase used. 
However, it is clear that a much smaller amount of the major compound mentioned 
earlier (Rf = 0.854) was found in the aqueous extract. 
 
 
Figure 4.1 TLC finger prints of three D. reticulata extracts. (A) TLC plate in 
Dichloromethane: Methanol (95:5) and (B) TLC plate in Chloroform: Methanol: 
Water (10:30:1). H, C and Aq denote the type of extracts (hexane, chloroform and 
aqueous extracts, respectively).  
H         C          Aq Aq
(A) (B)
Rf=0.854
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4.3  Phytochemical compositions  
Phytochemical screening analysis (Table 4.2) demonstrated the presence of 
alkaloids (Mayer’s test and Wagner’s test), triterpenoids (Salkowski’s test), flavonoids 
(Shinoda test and FeCl3 test), tannins (FeCl3 test and Lead acetate test) and 
polyphenols (Ferric-Chloride-Ferricyanide test) for the hexane and chloroform 
extracts, whereas saponin (Froth test), triterpenoids, tannins and polyphenols were 
present in the aqueous extract. However, cardiac glycosides (Keller Killiani test) and 
anthraquinone (Borntrager’s test) were absent from all extracts. 
 
4.4  Total phenolic content 
The Folin-Ciocalteau method was employed to determine the phenolic 
content, which was expressed in term of mg GAE/g extract. The mg GAE/g extract 
was calculated by using the gallic acid standard curve (Appendix A). As shown in 
Table 4.3, total phenolic contents of the hexane and chloroform extracts were not 
different (52.29 ± 1.33 and 53.89 ± 0.68 mg GAE/g extract, respectively), but 
significantly higher than that of the aqueous extract (33.21 ± 0.31 mg GAE/g extract, 
p<0.05).  
 
4.5  Antioxidant activity 
4.5.1 ABTS assay 
The results from ABTS radical scavenging assay of three extracts of D. 
reticulata and BHT (standard) are shown in Appendix B (B.1-B.4). The extracts and 
BHT expressed scavenging activity in a concentration-dependent manner. The IC50 
values for radical scavenging activity of extracts are summarized in Table 4.3. The 
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three extracts showed significant differences (p<0.05) in radical scavenging activity. 
Table 4.2  
Table 4.2 Phytochemical compositions of the chloroform, hexane, and aqueous    
…………...extracts from D. reticulata stem. 
Phytochemical 
Screening Tests 
Extract 
Hexane Chloroform Aqueous 
Alkaloids 
Mayer’s test 
Wagner’s  test 
 
+ 
+ 
 
+ 
+ 
 
- 
- 
Saponins 
Froth test 
 
- 
 
- 
 
+ 
Triterpenoids 
Salkowski’s test 
 
+ 
 
+ 
 
+ 
Flavanoids 
Shinoda  test 
FeCl3  test 
 
+ 
+ 
 
+ 
+ 
 
- 
- 
Tannins 
FeCl3  test 
Lead acetate test 
 
+ 
+ 
 
+ 
+ 
 
+ 
+ 
Cardiac glycosides 
Keller Killiani test 
 
- 
 
- 
 
- 
Anthraquinone 
Borntrager’s test 
 
- 
 
- 
 
- 
Polyphenol  
Ferric-chloride-Ferricyanide test 
 
+ 
 
+ 
 
+ 
(+) Presence, (-) Absence 
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It was found that chloroform extract had the lowest IC50 value (441.55 ± 13.56 µg/ml), 
followed by hexane extract (632.69 ± 23.02 µg/ml) and aqueous extract (1252.68 ± 
110.00 µg/ml). However, the antioxidant capacities of all extracts were lower than 
BHT of which IC50 in ABTS assay was 108.12 ± 8.41 µg/ml.  
4.5.2 DPPH assay 
The dose-response curves from DPPH radical scavenging assay of three 
extracts and ascorbic acid (as a standard) are shown in Appendix B (B.5-B.8) while 
their IC50 are summarized in Table 4.3. The results reveal that the aqueous extract had 
the lowest IC50 value (236.99 ± 10.98 µg/ml), followed by chloroform extract (570.56 
± 22.02 µg/ml) and hexane extract (717.37 ± 36.31 µg/ml). Ascorbic acid showed 
much more powerful in scavenging DPPH than the extracts with the IC50 of 1.86 ± 
0.12 µg/ml. 
4.5.3 FRAP assay 
The reducing potential of the extracts were calculated by using the FeSO4 
standard curve (Appendix A). The result was expressed as µmol Fe
2+
/mg dried extract. 
The FRAP value of extracts were not statistically different among all three extracts of 
D. reticulata as shown in Table 4.3.  
 
4.6  Effect of alloxan on the viability of HepG2 cells 
 Figure 4.2 shows the results from the cytotoxicity study of alloxan on HepG2 
cell. The half maximal inhibitory concentration (IC50) of alloxane on cell viability was 
found at 13.72 ± 0.27 mM, which was used to study the cytoprotective effect of 
extracts on alloxan-induced cells damage in the next experiment. 
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Table 4.3 Total phenolic content and antioxidant activities of D. reticulata extracts. 
 
Extract 
Total phenolic 
compound 
(mg GAE/g extract) 
ABTS assay 
(IC50 µg/ml) 
DPPH assay 
(IC50 µg/ml) 
FRAP assay 
(µmol Fe
2+
/mg dried 
extract) 
Hexane 52.29 ± 1.33
a 
441.55 ± 13.56
a, b, c 
714.37 ± 36.31
 a, b, c
 0.047 ± 0.036 
Chloroform 53.89 ± 0.68
a 632.69 ± 23.02
a, c 
570.56 ± 22.02
 a, c
 0.121 ± 0.028 
Aqueous 33.21 ± 0.31
 
1252.68 ± 110.00
c 
236.99 ± 10.98
 c
 0.091 ± 0.026 
BHT  - 108.12 ± 8.41 - - 
Ascorbic acid - - 1.86 ± 0.12 - 
Values are expressed as mean ± SD (n = 3). 
a
 p<0.05 statistically significant difference from aqueous extract. 
b
 p<0.05 statistically significant difference from chloroform extract.
 
c
 p<0.05 statistically significant difference from standard. 
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4.7  Effect of the extracts on the viability of HepG2 cells 
 As shown in Figures 4.3A and 4.3B, after treatment for 24 h, hexane and 
chloroform extracts at the concentrations higher than 60 µg/ml significantly decreased 
the viability of HepG2 cells compared to control (p<0.05);  While, the aqueous extract 
did not significantly decrease the cell viability at all concentrations (Figure 4.3C). 
Therefore, the hexane and chloroform extract at the concentration at 60 µg/ml were 
chosen for studying their cytoprotective effects on alloxan-induced cell damage. In 
case of the aqueous extract, the concentrations at 60, 500 and 5000 µg/ml were used 
since all of them did not show significant toxicity to the cell when compared to 
control. It should be noted that the vehicle (0.1% NaOH) did not cause any damage to 
the cells. 
 
4.8 Cytoprotective effect of the extracts on alloxan-induced HepG2 cell 
damage 
 The cytoprotective effect of extracts was evaluated on cell damage induced 
by alloxan at 14 mM for 2 h, which decreased cell viability to about 50% of control 
(Figure 4.4). After posttreatment of all extracts at the doses of 60µg/ml for 22 h, 
HepG2 cell viability was not significant altered compared to alloxan-treated cells. 
However, the aqueous extract at the concentrations at 500 and 5000 µg/ml showed 
significant protective potential by increasing HepG2 cell viability up to 62.41 ± 3.48% 
and 69.46 ± 3.77%, respectively.  
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4.9  Inhibitory effect of the extracts on α-glucosidase activity 
The α-glucosidase inhibition curves of three extracts of D. reticulate are 
shown in Appendix C. The effectiveness of enzymatic inhibition of extracts and 
acarbose were compared by their calculated IC50 (Table 4.4). The IC50 value acarbose, 
a positive control, was 157.95 ± 5.91 µg/ml. The three extracts showed significant 
differences (p<0.05) in α-glucosidase inhibition activity. It was found that chloroform 
extract showed the highest potential with the IC50 of 0.68 ± 0.10 µg/ml, followed by 
the hexane (IC50; 4.19 ± 0.28 µg/ml) and aqueous extracts (IC50; 411.62 ± 15.01 
µg/ml).  
 
 
Figure 4.2 Cytotoxicity effect of alloxan on HepG2 cell viability. Values are 
expressed as mean ± SD (n = 3). 
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Figure 4.3 Cytotoxicity effects of extracts. Panels A, B and C are cell viability of 
HepG2 cells after treated at various concentrations of hexane, chloroform and aqueous 
extracts, respectively. Values are expressed as mean ± SD (n = 3).
 
a
 p<0.05 statistically significant difference from control.
A 
B 
C 
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Figure 4.4 The effect of D. reticulata extracts on alloxan-induced HepG2 cell damage. ALX, H, C and Aq denote the type of chemical or 
extracts (alloxan, hexane extract, chloroform extract and aqueous extract, respectively).Values are expressed as mean ± SD (n = 3). 
a
 p<0.05 statistically significant difference form control. 
b
 p< 0.05statistically significant difference from alloxan. 
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Table 4.4 α-Glucosidase inhibition activity of the chloroform, hexane, and aqueous 
extracts from D. reticulata stem. 
 α – glucosidase inhibitory assay 
(IC50 µg/ml) 
Hexane extract 4.19 ± 0.28
 a, b, c
 
Chloroform extract 0.68 ± 0.10
 a, c 
Aqueous extract 411.62 ± 15.01
c 
Acarbose  157.95 ± 5.91
 
Values are expressed as mean ± SD (n = 3). 
a
 p<0.05 statistically significant difference from aqueous extract. 
b
 p<0.05 statistically significant difference from chloroform extract. 
c
 p<0.05 statistically significant difference from acarbose. 
 
 
 
 
 
 
 
 
 
 
CHAPTER V 
DISCUSSION AND CONCLUSION 
 
D. reticulata known in Thai as Cha-aim-nuea or Oi-sam-suan, has been 
traditionally used as an anti-coughing agent (Siri Ruckhachati Nature Park, 2010). The 
pharmacological activities of this plant discovered by scientific methods have also 
been documented, for example anti-rheumatism, anti-inflammatory and anti-
nociceptive (Laupattarakasem et al., 2003; Srimongkol et al., 2007) and antimicrobial 
(Khan et al., 2006). Recently, the aqueous extract of D. reticulata has been reported to 
possess anti-diabetic activity (Kumkrai et al., 2014). Moreover, mechanisms 
underlying the hypoglycemic activity of D. reticulata aqueous extract have been 
proposed. It has been suggested that the combination of cytoprotective effect, 
suppression of intestinal glucose absorption and inhibition of α-glucosidase activity 
are responsible for the anti-diabetic activity (Kumkrai et al., 2014; Kumkrai et al., 
2015). However, the active ingredients have not yet been identified.  
In general, it is difficult to isolate and identify active compounds that are 
responsible for a specific activity when a crude extract is used in an experiment 
because it contains too many compounds. Since the crude extract by hot water was 
used to study anti-diabetic activity of D. reticulata in the previous study, it is least 
likely to specify the active ingredient. In the present study, a sequential extraction 
method was used in order to separate several compounds in the stem of D. reticulata 
into three fractions in three different solvents, including hexane, chloroform and water.
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It was expected that all of the compounds could be extracted by these solvents which 
are different in polarity (from less to more polar: hexane, chloroform and water).  
From the previous report (Kumkrai et al., 2014), the aqueous extract of D. 
reticulata stem contained 16.7 yield % (w/w) of dried plant. In the present study, the 
extracts obtained were different from the previous report in terms of yield. Due to the 
polarity of the solvent, the hexane extract contained compounds which are more 
hydrophobic than the chloroform and aqueous extracts. D. reticulata stem appeared to 
contain more hydrophilic than hydrophobic compounds because the percentage of 
yield from the aqueous extract was about 5 times to the others (about 10% compare to 
about 2%). 
 Due to hydrophobic property of the compounds in hexane and chloroform 
extracts, there were difficulties in finding a suitable solvent to dissolve the extract for 
future experiments when water media was needed. It was found that solubility of the 
extracts was improved after adjusting to higher pH. It is worth noting that NaOH at all 
concentrations used to improve the solubility was tested and it appeared to have no 
effect in all experiments.   
 The constituents of all extracts were first screened by TLC. As seen in Figure 
4.1, fewer components were found in the hexane extract compared to the chloroform 
extract. However, at least one major compound (Rf = 0.854) was found in both 
extracts. Compared to the previous report from a group of researchers 
(Laupattarakasem et al., 2003), it was suggested that this compound would be 
lupinifolin. However, this prediction needs to be clarified with further experiments.   
 In the case of aqueous extract, the compounds were not separated well in both 
types of mobile phase used. Nevertheless, it can be seen that the constituents of 
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aqueous extract are different from those of the other extracts. Moreover, it is quite 
clear that the amount of the major compound mentioned earlier (Rf= 0.854) was much 
less or not found in the aqueous extract.  
 The results from phytochemical analysis revealed that none of the extracts 
from D. reticulata stem contained cardiac glycosides and anthraquinone, whereas 
triterpenoids, tannins and polyphenol were detected in all three extracts. Saponin 
appeared to be found only in the aqueous extract. Flavanoids and alkaloids seemed to 
be completely extracted by hexane and chloroform because these types of compound 
could not be detected in the aqueous extract by the phytochemical screening methods 
used. In the case of flavonoids, this is in accordance with the major compound 
lupinifolin that was mentioned earlier. Lupinifolin is a flavanoid that has been isolated 
from several plants in Derris genus, including D. reticulata. It is water insoluble, but 
very soluble in organic solvents, especially in hexane, chloroform and ethanol. This 
could be an explanation that flavonoids were not found in the aqueous extract and the 
band with Rf at 0.854 in the aqueous extract was not seen on TLC.  
D. reticulata extract has been shown to possess antioxidant and anti-diabetic 
activities. It has been proposed that the anti-diabetic activity of aqueous extract is 
partly due to cytoprotective effect by its antioxidant compounds (Kumkrai et al., 
2014). It is suggested that an increase in sugar level induces an elevation of oxidant 
level and/or a decreased function of antioxidants (Mshelia, 2004; Dominique, 2002). 
Thus, these two factors are causes of oxidative stress and oxidative stress partly 
involved in diabetes complications such as cardiovascular diseases, hypertension and 
nephropathy-(American Diabetes Association, 2012; Dominique, 2002; Mshelia, 
2004). Normally, the excess free radicals can be removed from the body by 
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antioxidant pathways such as superoxide dismutase, catalase, glutathione peroxidase, 
and thiol antioxidant (Bierhaus et al., 1998; Dominique, 2002). In addition, the excess 
free radicals can also be destroyed by external antioxidants such as supplements 
containing vitamin C, flavonoids and carotenoids, which can be found in plants, 
vegetables and fruits (Valko et al., 2007). 
It has been reported that the antioxidant activity of plant materials is well 
correlated with the content of their phenolic compounds (Xin-Hua, Chang-Qing, Xing-
Bo, and Lin-Chun, 2001). In this study, it was found that the aqueous extract contained 
fewer total phenolic compounds than the other two extracts. Antioxidant activities of 
the extracts were further examined and it was found that the hexane and chloroform 
extracts exhibited significantly more antioxidant potential than the aqueous extract by 
ABTS assay. Conversely, with DPPH scavenging method, the aqueous extract showed 
strongest antioxidant activity with the lowest IC50 among three extracts. The results 
found in the present study are in accordance with the study reported by a group of 
researchers (Antolovich et al., 2002) that the DPPH scavenging activity is correlated 
with phenolic compounds, but not flavonoids. Since flavonoids were detected in both 
hexane and chloroform, but not in the aqueous extract, the results implicate that major 
compounds in both hexane and chloroform extract were flavonoids of which 
antioxidant activity would not be measured by DPPH scavenging method. Therefore, 
the IC50 of the hexane and chloroform extracts obtained from DPPH scavenging assay 
were found higher than the aqueous extract, in spite of the fact that they contained 
more total phenolic contents.  
Together with preliminary phytochemical analysis, it was suggested that the 
major compounds that were responsible for antioxidant activities of hexane and 
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chloroform extracts could be flavonoids or tannins which have been reported to 
possess antioxidant activity (Saxena et al., 2013). In contrast, as flavonoids were not 
detected in the aqueous extract, other classes of phytochemicals, such as tannin and 
polyphenol, may be responsible for its antioxidant effects (Saxena et al., 2013). 
Ferric reducing antioxidant power (FRAP) assay were also performed to 
determine the antioxidant activity of D. reticulata extracts. As shown in Table 4.3, the 
three extracts possessed no significant differences in reducing power activity.  
 The methods for determination of antioxidant activities discussed earlier are 
useful only for estimating antioxidant capacities of chemical in vitro because living 
cells are not involved in the experiments. To be more relevant, the antioxidant activity 
of D. reticulata extracts were tested in the human hepatoma HepG2 cells to show a 
biologically relevance using alloxan as a free radical source.  
 The liver is an organ which plays an essential role in maintaining normal 
physiology and it is also a vulnerable target of many drugs or other chemicals. The 
safety and protective evaluation in this study was performed using alloxan as an 
oxidative stress agent to induce cell damage. The IC50 of alloxan (14 mM) found in the 
present study was similar to that from the previous study (Kumkrai et al., 2014), using 
RINm5F cells (9 mM).   
 Cytotoxicity studies of all extracts were conducted and the results showed 
that the aqueous extract had less toxicity to HepG2 cells than the other extracts. After 
treated with the aqueous extract at the concentrations up to 5000 µg/ml overnight, cell 
viability was not significantly decreased compared to control.  In contrast, after 
exposure of hexane and chloroform extracts at the concentrations higher than 60 
µg/ml, cell death increased significantly. Therefore, in further experiments, the 
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concentrations of hexane and chloroform extracts were limited at 60 µg/ml, for 
otherwise the extracts themselves might have synergized the toxicity of alloxan, 
instead of protection. 
 In the cytoprotective study, the result revealed that all extracts at the 
concentration of 60 µg/ml were not be able to protect HepG2 cells from the damage 
induced by alloxan. However, the aqueous extract at the doses of 500 and 5000 µg/ml 
possessed cytoprotective effect by increasing cell viability from about 50% up to 70%. 
The results obtained from this experiment support the proposed mechanism for anti-
diabetic action of D. reticulata aqueous extract by its cytoprotective effect. However, 
the mechanisms underlying this protective effect and whether or not it is involved in 
antioxidant activity still remain elusive.  
Except for the antioxidant activity to protect oxidative stress from oxidant 
agents, another mechanism which was proposed to responsible for anti-diabetic 
activity of D. reticulata extract was the inhibition of α-glucosidase enzyme (Kumkrai 
et al., 2014). This enzyme has the property to breakdown carbohydrates to 
monosaccharide before absorption. The inhibition of intestinal α-glucosidase delays 
the digestion of carbohydrates and reduces the rate of glucose absorption 
(International Union of Biochemistry and Molecular Biology, 2010; Burkhard  and 
Christine, 1998). Thus, in this study α-glucosidase inhibitory effects of three D. 
reticulata extracts were compared. As shown in Table 4.4, the result indicates that all 
of D. reticulata extracts have α-glucosidase inhibitory activity. However, the 
chloroform extract showed the highest potency (IC50; 0.68 ± 0.10 µg/ml). The hexane 
extract also exhibited high potential in inhibiting the enzyme activity with the IC50 of 
4.19 ± 0.28 µg/ml which is lower than acarbose, a standard drug. The active ingredient 
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may be the chemical on TLC at Rf = 0.854. The IC50 of the aqueous extract was found 
at 411.62 µg/ml which implied that it had much lower inhibitory effect than the other 
extracts. The activity of the aqueous extract in this study was comparable to the 
activity of the aqueous extract of D. reticulata reported previously (917.29 µg/ml). As 
mentioned earlier, the major compound present in the hexane and chloroform extracts 
was not detected in the aqueous extract. Taken together, it is possible that the 
compound on TLC at Rf = 0.854 may be the active ingredient for inhibition of α-
glucosidase enzyme. The flavonoid lupinifolin has been reported to be a major 
compound in D. reticulata (Chivapat, Chavalittumrong, Attiwist, and 
Soonthornchareonnon,  2009). Hence, the compound which was detected at Rf = 0.854 
in this study might be lupinifolin and may be responsible for α-glucosidase inhibitory 
activity of both hexane and chloroform extracts. However, further experiments are 
necessary for verification. Thus, the isolation and identification of this compound 
including the examination of its antioxidant, α-glucosidase inhibitory and anti-diabetic 
activities are interesting for the future study. 
In conclusion, the present study has demonstrated that the compositions 
found in hexane and chloroform extracts by phytochemical screening test were similar, 
but different from those found in the aqueous extract. The major compound of the 
hexane and chloroform extracts appeared to be the same which was detected at Rf = 
0.854 on TLC. Instead, this compound was likely not present in the aqueous extract. 
All three extracts of D. reticulata possessed in vitro antioxidant activities with 
different degrees of power depend on the method used. From the cytotoxic test, 
hexane and chloroform extracts produced more toxic effects than the aqueous extract 
on HepG2 cell viability. All extracts at the dose of 60 µg/ml failed to protect cells 
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from the damage induced by alloxan, however, higher doses of the aqueous extracts 
produced a cytoprotective effect to HepG2 cells. Finally, the chloroform extract 
exhibited the strongest inhibitory effect on α-glucosidase activity followed by hexane 
extract, whereas the aqueous extract showed the weakest effect. Its IC50 was 600 times 
higher than the IC50 of chloroform extract. 
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A.1 Standard gallic acid 
 
 
 
A.2 Standard FeSO4 
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B.1 ABTS assay 
 
 
B.2 ABTS assay 
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B.3 ABTS assay 
 
B.4 ABTS assay 
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B.5 DPPH assay 
 
B.6 DPPH assay 
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B.7 DPPH assay 
 
B.8 DPPH assay 
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C.1 α-glucocidase inhibitory activity assay 
 
 
 
C.2 α-glucocidase inhibitory activity assay 
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C.3 α-glucocidase inhibitory activity assay 
 
 
 
C.4 α-glucocidase inhibitory activity assay 
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Chemicals and instruments  
 All chemicals and instruments used in this study are listed in Table 1 and 2. 
Table 1 List of chemicals used in the study. 
 
Name Source 
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) Sigma 
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical Aldrich 
2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) Flukar 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) 
Invitrogen 
Acetic acid glacial Carlo erba 
Ammonia Panreac 
Antibiotic-antimitotic solution  Gibco 
Acarbose Fluka 
Ascorbic acid Carlo erba 
Acetone Loba chemic 
Benzene Loba chemic 
Butylated hydroxytoluene (BHT) Flukar 
Chloroform Analar nornapur 
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Table 1 List of chemicals used in the study (Continued). 
 
Name Source 
Dichloromethane Carlo erba 
Dimethylsulphoxide (DMSO) Carlo erba 
Dulbecco’s modified eagle medium (DMEM) Gibco 
Ethanol Aci labscan 
Ethyl alcohol Univar 
Ferric chloride (FeCl3) Fisher chemical 
Ferrous sulfate (FeSo4) Carlo erba 
Fetal bovine serum Gibco 
Folin-Ciocalteau reagent Carlo 
Gallic acid Fluka 
HEPES Gibco 
Hexane Aci labscan 
Hydrochloric acid (HCl) Carlo erba 
Iodine Univar 
Lead acetate Loba chemie 
Magnesium ribbon Aldrich 
Mercury chloride (HgCl2) Univar 
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Table 1 List of chemicals used in the study (Continued). 
 
Table 2 List of instruments used in the study. 
Name Source 
96-well plate Nunc 
Analytical balance Ohaus 
 
Name Source 
Methanol Lobal chemie 
Sodiun hydroxide (NaOH) Univar 
Potassium iodide (KI) Univar 
Potassium ferricyanide Univar 
Sodium acetate trihydrate Gibco 
Sodium carbonate Carlo 
Sodium pyruvate Gibco 
Sulphuric acid Univar 
TLC silica gel 60 F254 Merck kgaa 
Trypan blue  Gibco 
0.25% trypsin-EDTA Gibco 
Tween 80 Bio-rad 
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Table 2 List of instruments used in the study (Continued). 
 
Name Source 
Autoclave Hirayama 
Centrifuge machine Hettich 
ELISA plate reader Bio-rad 
Haemocytometer Fisher Scientific 
Heating mantle with digital  Tops 
Hot air over Memmert 
Lyophilizer Labconco 
Micropipette Eppendorf 
Microscope (model CKX4) Olympus 
Microscope (model CX21) Olympus 
Rotary evaporator Buchi 
Soxhlet extractor Sigma Adldrich 
Spectrophotometer Cecil 
Tissue culture flask Nunc 
TLC developing tank Sigma Adrich 
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